Insulet (PODD) Net Equity Issued and Repurchased (2010 - 2019)
Insulet (PODD) posted Net Equity Issued and Repurchased of -$9.1 million for Q2 2019, down 200.0% on a QoQ basis from $9.1 million in Q1 2019, and down 209.9% year-over-year from $8.2 million in Q2 2018.
Insulet (PODD) Net Equity Issued and Repurchased (2010 - 2019) Analysis & Trends
Insulet's Net Equity Issued and Repurchased history runs 10 years deep, the most recent figure standing at -$9.1 million for Q2 2019.
- Quarterly Net Equity Issued and Repurchased fell 209.9% year-over-year to -$9.1 million in Q2 2019, while the trailing twelve-month figure through Sep 2020 was -$9.1 million (up 32.7% YoY) and the FY2020 annual result came in at $477.5 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased was -$9.1 million for Q2 2019 at Insulet, down from $9.1 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $9.1 million in Q1 2019 and bottomed at -$13.5 million in Q4 2018.
- A 5-year average of $1.4 million and a median of $1.6 million in 2015 frame the typical range for Net Equity Issued and Repurchased.
- Annual changes were most pronounced in 2017 — Net Equity Issued and Repurchased jumped 695.85% — and 2019, when it tumbled 209.9%.
- Insulet's Net Equity Issued and Repurchased stood at $808000.0 in 2015, then sank by 99.26% to $6000.0 in 2016, then soared by 47300.0% to $2.8 million in 2017, then tumbled by 573.42% to -$13.5 million in 2018, then jumped by 32.7% to -$9.1 million in 2019.
- Business Quant data shows PODD's Net Equity Issued and Repurchased at -$9.1 million in Q2 2019, $9.1 million in Q1 2019, and -$13.5 million in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 12.70 Mn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Insulet | 11.52 Bn | 11.04 Bn | 529.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2019 | -9.06 Mn |
| Jun 30, 2019 | -9.06 Mn |
| Mar 31, 2019 | 9.06 Mn |
| Mar 31, 2019 | 9.06 Mn |
| Dec 31, 2018 | -13.46 Mn |
| Dec 31, 2018 | -13.46 Mn |
| Sep 30, 2018 | 2.26 Mn |
| Sep 30, 2018 | 2.26 Mn |
| Jun 30, 2018 | 8.25 Mn |
| Jun 30, 2018 | 8.25 Mn |
| Mar 31, 2018 | 2.96 Mn |
| Mar 31, 2018 | 2.96 Mn |
| Sep 30, 2017 | 2.84 Mn |
| Sep 30, 2017 | 2.84 Mn |
| Jun 30, 2017 | 1.56 Mn |
| Jun 30, 2017 | 1.56 Mn |
| Mar 31, 2017 | 6.34 Mn |
| Mar 31, 2017 | 6.34 Mn |
| Dec 31, 2016 | 6,000.00 |
| Dec 31, 2016 | 6,000.00 |